Back to search
FDAFDA · Food and drugs·Recall number D-0162-2023

Levofloxacin Tablets, USP 500 mg; 50-count bottles, Rx Only, Manufactured for: Macleods Pharma USA, Inc. Princeton, NJ 08540; Manufactured by: Macleods Pharmaceuticals Ltd., Baddi, Himachal Pradesh, India. NDC 33342-022-08

Published January 25, 2023 · Recall initiated: January 5, 2023

Summary

FDA records drug Class III recall D-0162-2023, published January 25, 2023 and initiated January 5, 2023. Recalling firm: MACLEODS PHARMA USA, INC; Status: Terminated; Reported quantity: 10052 bottles; Lot: Lot #: BLF2214A; Exp. 06/2025. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Mismatching of the embossing on the tablets (T7) with the embossing mentioned in the package insert (ML63) in the distributed bottles.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
MACLEODS PHARMA USA, INC
Distributor
Nationwide within United States and Puerto Rico.
Lot
Lot #: BLF2214A; Exp. 06/2025
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Levofloxacin Tablets, USP 500 mg; 50-count bottles, Rx Only, Manufactured for: Macleods Pharma USA, Inc. Princeton, NJ 08540; Manufactured by: Macleods Pharmaceuticals Ltd., Baddi, Himachal Pradesh, India. NDC 33342-022-08 recalled?

Yes. FDA published recall D-0162-2023 on January 25, 2023. Reported hazard: Mismatching of the embossing on the tablets (T7) with the embossing mentioned in the package insert (ML63) in the distributed bottles.

What should I do if I have this product?

Voluntary: Firm initiated · Letter